Search results for BSX

After the Trust Shock: A High-Quality Franchise at a Rare Discount

Boston Scientific shares have been cut roughly in half since mid-2025, driven by a guidance cut, competitive headwinds in electrophysiology, softening WATCHMAN procedure volumes, and a Class I pacemaker recall. Yet the company still posted 9.4% organic growth in Q1 2026, is on...